A case of successful treatment of concurrent verrucous epidermal naevi and psoriasis with apremilast.
psoriasis
Journal
The Australasian journal of dermatology
ISSN: 1440-0960
Titre abrégé: Australas J Dermatol
Pays: Australia
ID NLM: 0135232
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
revised:
27
03
2023
received:
28
02
2023
accepted:
06
04
2023
medline:
11
8
2023
pubmed:
18
4
2023
entrez:
17
4
2023
Statut:
ppublish
Résumé
In a rare case of concurrent verrucous epidermal naevi (VEN) with psoriasis, previous treatments with oral methotrexate and acitretin showed minimal improvement. However, treatment with oral apremilast resulted in complete resolution of psoriasis and significant improvement in VEN lesions after 1 month. This is the first documented case of successful VEN treatment with apremilast, highlighting its potential efficacy in treating verrucous epidermal naevus. Further studies are needed to validate its effectiveness.
Substances chimiques
apremilast
UP7QBP99PN
Acitretin
LCH760E9T7
Anti-Inflammatory Agents, Non-Steroidal
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e299-e301Informations de copyright
© 2023 Australasian College of Dermatologists.
Références
Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest. 2006;116(8):2201-7.
Masatkar V, Gupta LK, Mehta S, Khare AK, Mittal A. Nevoid psoriasis coexisting with verrucous epidermal nevus. Indian Dermatol Online J. 2017;8(2):150-2.
Kim TI, Jeong KH, Shin MK. Verrucous epidermal nevus (VEN) successfully treated with indocyanine green (ICG) photodynamic therapy (PDT). JAAD Case Rep. 2015;1(5):312-4.
Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol. 2012;83(12):1583-90.
Mammone T, Marenus K, Maes D, Lockshin RA. The induction of terminal differentiation markers by the cAMP pathway in human HaCaT keratinocytes. Skin Pharmacol Physiol. 1998;11(3):152-60.